This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Joerk Zwicker: Innovator in Gene Therapy
Introduction
Joerk Zwicker is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of gene therapy, particularly through his innovative work on nucleic acid constructs. His research focuses on the regulation of gene expression, which has important implications for treating various disorders.
Latest Patents
Joerk Zwicker holds a patent for "Nucleic acid constructs for the cell cycle-regulated expression of genes." This patent describes nucleic acid constructs that include an activator sequence, a promoter module, and a structural gene. The promoter module features a CHR region and a nucleic acid sequence that binds a protein of the E2F family. These constructs are particularly useful in gene therapy applications, especially for disorders characterized by excessive cell proliferation. He has 1 patent to his name.
Career Highlights
Throughout his career, Joerk Zwicker has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and biotechnology sectors. His work has contributed to advancements in gene therapy, showcasing his commitment to improving medical treatments through innovative research.
Collaborations
Joerk has collaborated with esteemed colleagues such as Rolf Mueller and Hans-Harald Sedlacek. These partnerships have further enhanced his research and development efforts in the field of gene therapy.
Conclusion
Joerk Zwicker's contributions to gene therapy through his innovative patents and collaborations highlight his role as a significant figure in the scientific community. His work continues to pave the way for advancements in medical treatments.